At DRADS, we invest in brilliant people with transformative ideas to solve difficult problems. @thelivegreenco checks these boxes in building the #futureoffood, and we are delighted to lead their Series Pre-A! Announcement: https://t.co/plMyM2Z9D9
We are happy to announce that we have invested in @AmylyxPharma! We look forward to working with them and witnessing their game-changing approaches to therapeutics.
#pharma#biotech#VentureCapital
We are excited to announce that we have invested in @zammoai! Zammo's solution tackles the lack of connectedness between voice enabled services, enabling cross-talk between different voice activated technologies. Applicable across many fields, Zammo will be a real game changer.
We have officially partnered with @HyperfineR, closing as a Series D investor. Hyperfine is introducing a completely new dimension to patient care with their portable MRI. We are honored to be a part of their mission of democratizing healthcare.
#innovation#VentureCapital
📢 Exciting news from AZTherapies! We believe that @garidel_de will be an amazing CEO for AZTherapies. We look forward to all the progress AZT will make under Marc's guidance.
#biotech#VentureCapital#Pharmaceutical
https://t.co/KtIz8HQ1Wa
We are absolutely delighted to hear about this great news from AZTherapies. As major shareholders of AZT we look forward to many more milestones from this amazing company that will definitely change the game for neurodegenerative disease therapeutics.
https://t.co/8OWh7hPPS1
AZTherapies has announced that it is appointing Noah Gottdiener of @duffandphelps and @thierryporte_ of J.C. Flowers & Co. to their Board of Directors. In addition, Retired @LillyPad Executive Joseph B. Kelley will be appointed to their Business Advisory Board.
#VentureCapital
We have officially partnered with @ROKIT_GBD, closing as a major Series C investor. Rokit is ushering the future of regenerative medicine with its customized artificial organ platform, and we are honored to be a part of that journey!
#Innovation#Biotechnology#VentureCapital